Coagtech

While optimizing coagulant chemical dosing is a genuine real-world problem with practical utility, the submission contains highly exaggerated, vague, and unsupported claims (such as an audience reach of 'everyone' and traction claiming 'most people have used my product'). The glaring disparity between the B2B niche reality and the provided inputs results in severe penalties across traction, reach, and response quality, placing it well below the calibration baseline.